Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Alv B Logo
Alv B CB Rank
903812
Heat Score
54
Alv B biotech company developing experimental cancer treatments for cats and dogs.
Private Oslo, Oslo, Norway1-10 alvb.no
Biotechnology
Oncology
Pet
Veterinary
Overview

Alv B
Heat Score
54

Growth Score
pts
in past quarter
Heat Score 54
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Alv B

CB Rank
903812
Alv B biotech company developing experimental cancer treatments for cats and dogs.
Private Oslo, Oslo, Norway1-10 alvb.no
Biotechnology
Oncology
Pet
Veterinary

Key People

Details

Legal Name Alv B AS
Operating Status Active
Company Type For Profit
Founders  Chris Falchenberg
Phone Number 47 40671609
Contact Email contact@alvb.no
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nebumet
Nebumet is a nebulized immunotherapy for dogs that treats and prevents lung metastases in solid tumors by delivering a BCG vaccine formulation directly to the lungs.

Research & Development

Alv B is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 1 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 7, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 28, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$33.2KThis year, Alv B is projected to spend $33.2K on IT, according to Aberdeen.

Active Website Tech Count

22Alv B is actively using 22 technologies for its website, according to BuiltWith. These include DNSSEC, SPF, and  U.S. Server Location.

Total IP

2The intellectual property of Alv B includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Alv B's headquarters? Alv B is located in Oslo, Oslo, Norway.Who are Alv B's competitors? Alternatives and possible competitors to Alv B may include ImpriMed, Zoetis, and  FidoCure.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|